ReviewEuropean respiratory review : an official journal of the European Respiratory Society2016
Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis).
Review in European respiratory review : an official journal of the European Respiratory Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 45 citations in OpenAlex.
- Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.Pediatric blood & cancer · 2019Trial
- Kaposiform lymphangiomatosis-the effects of long-term treatment with sirolimus: case series study and review of the literature.Frontiers in medicine · 2026Article
- Multimodal treatment strategies in generalized lymphatic anomaly with pleural effusion: a case study and literature review.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025Article
- Scrotal lymphangioma in an infant: A compelling case study of comprehensive diagnosis and management.Urology case reports · 2025Article
- Lymphatic malformations involving the thorax in children: a retrospective cohort study.BMC pulmonary medicine · 2025Article
- Imaging and Clinical Features of Primary Thoracic LymphangiomaCurrent medical imaging · 2025Article
- Minimally invasive triumph: the role of thoracic duct embolization in managing severe post-esophagectomy chylothorax.American journal of translational research · 2025Article
- Lymphangiomatosis diagnosed using transbronchial lung cryobiopsy: A case report.Respiratory medicine case reports · 2025Article
- Pulmonary lymphangiomatosis: insights into an ultra-rare disease.Respiratory research · 2024Article
- Diffuse pulmonary lymphangiomatosis as a differential diagnosis of anterior mediastinal mass.Journal of surgical case reports · 2024Article
- Generalized cystic lymphangiomatosis incidentally diagnosed in an asymptomatic adult: Imaging findings of a very rare case.Radiology case reports · 2024Article
- The lymphatic vasculature in lung function and respiratory disease.Frontiers in medicine · 2023Review
- Impact of High Fat Diet and Bolus Feeding on Chyle Accumulation in a Mouse Model of Generalized Lymphatic Anomaly.Lymphatic research and biology · 2022Article
- Neonatal Generalized Lymphatic Anomaly with Skin Involvement.Annals of dermatology · 2021Article
- Effective Initial Treatment of Diffuse Pulmonary Lymphangiomatosis with Sirolimus and Propranolol: A Case Report.Medicina (Kaunas, Lithuania) · 2021Article
- A perplexing airspace: peace of mind now or later.Breathe (Sheffield, England) · 2021Article
- Article
- Thoracic involvement of diffuse lymphangiomatosis successfully treated with sildenafil.BMJ case reports · 2019Article
- Why we should care about ultra-rare disease.European respiratory review : an official journal of the European Respiratory Society · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generalised lymphatic anomaly (GLA), also known as lymphangiomatosis, is a rare disease caused by congenital abnormalities of lymphatic development. It usually presents in childhood but can also be diagnosed in adults. GLA encompasses a wide spectrum of clinical manifestations ranging from single-organ involvement to generalised disease. Given the rarity of the disease, most of the information regarding it comes from case reports. To date, no clinical trials concerning treatment are available. This review focuses on thoracic GLA and summarises possible diagnostic and therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.